Cargando…
Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713812/ https://www.ncbi.nlm.nih.gov/pubmed/31467852 http://dx.doi.org/10.1016/j.ymgmr.2019.100506 |
_version_ | 1783446937105596416 |
---|---|
author | Favresse, Julien Gruson, Damien Gheldof, Damien |
author_facet | Favresse, Julien Gruson, Damien Gheldof, Damien |
author_sort | Favresse, Julien |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6713812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-67138122019-08-29 Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” Favresse, Julien Gruson, Damien Gheldof, Damien Mol Genet Metab Rep Letter to the Editor Elsevier 2019-08-22 /pmc/articles/PMC6713812/ /pubmed/31467852 http://dx.doi.org/10.1016/j.ymgmr.2019.100506 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Letter to the Editor Favresse, Julien Gruson, Damien Gheldof, Damien Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
title | Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
title_full | Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
title_fullStr | Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
title_full_unstemmed | Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
title_short | Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
title_sort | comment on “high doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: implications for individuals with biotin-responsive inherited metabolic disorders” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713812/ https://www.ncbi.nlm.nih.gov/pubmed/31467852 http://dx.doi.org/10.1016/j.ymgmr.2019.100506 |
work_keys_str_mv | AT favressejulien commentonhighdosesofbiotincaninterferewithimmunoassaysthatusebiotinstreptavidintechnologiesimplicationsforindividualswithbiotinresponsiveinheritedmetabolicdisorders AT grusondamien commentonhighdosesofbiotincaninterferewithimmunoassaysthatusebiotinstreptavidintechnologiesimplicationsforindividualswithbiotinresponsiveinheritedmetabolicdisorders AT gheldofdamien commentonhighdosesofbiotincaninterferewithimmunoassaysthatusebiotinstreptavidintechnologiesimplicationsforindividualswithbiotinresponsiveinheritedmetabolicdisorders |